A Commonwealth Fund brief looks at using reference pricing for drugs.
Read More
A MedPAC presentation covers clinician payment trends and analysis.
A study published in the Journal of the American Medical Association examines disparities in hospitalization outcomes.
JAMA has a couple of interesting research letters regarding uptake of biosimilars.
Prominent health economist Victor Fuchs discusses the “efficiency” of the US health care system.
A Mark Farrah Associates brief shows that as of mid-year, health plans are having good results across all lines of business.
Two studies in the Journal of the American Medical Association discuss results from the first year of the Medicare joint replacement bundled payment demonstration.
Hard to figure out what is really happening with premiums for health insurance purchased on the reform law exchanges.
Today, we hear from the PBM trade association, pointing (or giving) the finger at medication makers for high prices.
In the frenzy over drug prices, all sides are releasing studies on who is to blame. Here is one sponsored by the drug manufacturers’ trade association.
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.